Protective Effect of Kaempferol on LPS plus ATP-Induced Inflammatory Response in Cardiac Fibroblasts

Inflammation

Volumn 38, Issue 1, 2015, Pages 94-101

  Tang, Xi Lan ^a,b   Liu, Jian Xun ^a   Dong, Wei ^b   Li, Peng ^a   Li, Lei ^a   Hou, Jin Cai ^a   Zheng, Yong Qiu ^a   Lin, Cheng Ren ^a   Ren, Jun Guo ^a  

^a XIYUAN HOSPITAL   (China)

^b JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Akt; cardiac fibroblasts; inflammatory response; kaempferol; NF B

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIINFLAMMATORY AGENT; DRUG THERAPY; DRUG TOXICITY; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; KAEMPFEROL; KAEMPFEROL DERIVATIVE; LIPOPOLYSACCHARIDE; PHARMACOLOGY; PROTECTIVE AGENT; PROTEIN KINASE B; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DRUG EFFECTS; DRUG MECHANISM; ENZYME PHOSPHORYLATION; FIBROBLAST; HEART MUSCLE CELL; HEART PROTECTION; INFLAMMATION; METABOLISM; MTT ASSAY; NEWBORN; NONHUMAN; PHYSIOLOGY; PREVENTION; PROTEIN PHOSPHORYLATION; RAT; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANIMALS, NEWBORN; ANTI-INFLAMMATORY AGENTS; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EFFECTS; FIBROBLASTS; INFLAMMATION; KAEMPFEROLS; LIPOPOLYSACCHARIDES; METABOLISM; MYOCYTES, CARDIAC; PHARMACOLOGY; PHYSIOLOGY; PREVENTION AND CONTROL; RATS, SPRAGUE-DAWLEY; THERAPEUTIC USE; TOXICITY;

EID: 84964255463     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-0011-2     Document Type: Article

References (31)

1. Bartunek, J., and M. Vanderheyden. 2012. Inflammation and related biomarkers in cardiovascular disease. Biomarkers in Medicine 6: 1–3.
2. Grundmann, S., C. Bode, and M. Moser. 2011. Inflammasome activation in reperfusion injury: friendly fire on myocardial infarction? Circulation 123: 574–576.
3. Lindner, D., C. Zietsch, J. Tank, S. Sossalla, N. Fluschnik, S. Hinrichs, L. Maier, W. Poller, S. Blankenberg, H.P. Schultheiss, C. Tschöpe, and D. Westermann. 2014. Cardiac fibroblasts support cardiac inflammation in heart failure. Basic Research in Cardiology 109: 428. doi:10.1007/s00395-014-0428-7.
4. Shinde, A.V., and N.G. Frangogiannis. 2014. Fibroblasts in myocardial infarction: a role in inflammation and repair. Journal of Molecular and Cellular Cardiology 70: 74–82.
5. Kawaguchi, M., M. Takahashi, T. Hata, Y. Kashima, F. Usui, H. Morimoto, A. Izawa, Y. Takahashi, J. Masumoto, J. Koyama, M. Hongo, T. Noda, J. Nakayama, J. Sagara, S. Taniguchi, and U. Ikeda. 2011. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation 123: 594–604.
6. Sandanger, Ø., T. Ranheim, L.E. Vinge, M. Bliksøen, K. Alfsnes, A.V. Finsen, C.P. Dahl, E.T. Askevold, G. Florholmen, G. Christensen, K.A. Fitzgerald, E. Lien, G. Valen, T. Espevik, P. Aukrust, and A. Yndestad. 2013. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischemia-reperfusion injury. Cardiovascular Research 99: 164–174.
7. Calderón-Montaño, J.M., E. Burgos-Morón, C. Pérez-Guerrero, and M. López-Lázaro. 2011. A review on the dietary flavonoid kaempferol. Mini Reviews in Medicinal Chemistry 11: 298–344.
8. Tang, X.L., J.X. Liu, W. Dong, P. Li, L. Li, C.R. Lin, Y.Q. Zheng, J.C. Hou, and D. Li. 2013. The cardioprotective effects of citric acid and L-malic acid on myocardial ischemia/reperfusion injury. Evidence-based Complementary and Alternative Medicine. doi:10.1155/2013/820695.
9. Lin, M.K., Y.L. Yu, K.C. Chen, W.T. Chang, M.S. Lee, M.J. Yang, H.C. Cheng, C.H. Liu, Dz.C. Chen, and C.L. Chu. 2011. Kaempferol from semen cuscutae attenuates the immune function of dendritic cells. Immunobiology 216: 1103–1109.
10. An, G.H., J. Gallegos, and M.E. Morris. 2011. The bioflavonoid kaempferol is an Abcg2 substrate and inhibits Abcg2-mediated quercetin efflux. Drug Metabolism and Disposition 39: 426–432.
11. Kim, H.P., K.H. Son, H.W. Chang, and S.S. Kang. 2004. Anti-inflammatory plant flavonoids and cellular action mechanisms. Journal of Pharmacological Sciences 96: 229–245.
12. Park, S.E., K. Sapkota, S. Kim, H. Kim, and S.J. Kim. 2011. Kaempferol acts through mitogen-activated protein kinases and protein kinase B/AKT to elicit protection in a model of neuroinflammation in BV2 microglial cells. British Journal of Pharmacology 164: 1008–1025.
13. Chen, X.J., X.F. Yang, T.J. Liu, M.F. Guan, X.R. Feng, W. Dong, X. Chu, J. Liu, X.L. Tian, X.X. Ci, H.Y. Li, J.Y. Wei, Y.H. Deng, X.M. Deng, G.F. Chi, and Z.L. Sun. 2012. Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in mice. International Immunopharmacology 14: 209–216.
14. Cao, R.F., K.Q. Fu, X.P. Lv, W.S. Li, and N.S. Zhang. 2014. Protective effects of kaempferol on lipopolysaccharide-induced mastitis in mice. Inflammation. doi:10.1007/s10753-014-9870-9.
15. Lee, W.S., E.G. Lee, M.S. Sung, and W.H. Yoo. 2014. Kaempferol inhibits IL-1β-stimulated, RANKL-mediated osteoclastogenesis via downregulation of MAPKs, c-Fos, and NFATc1. Inflammation. doi:10.1007/s10753-014-9849-6.
16. Kuruvilla, L., and C.C. Kartha. 2009. Treatment with TNF-α or bacterial lipopolysaccharide attenuates endocardial endothelial cell-mediated stimulation of cardiac fibroblasts. Journal of Biomedical Science 16. doi: 10.1186/1423-0127-16-21
17. Chen, K., D.Y. Li, X.J. Zhang, P.L. Hermonat, and J.L. Mehta. 2012. Anoxia-reoxygenation stimulates collagen type-I and MMP-1 expression in cardiac fibroblasts modulation by the PPAR-γ ligand pioglitazone. Journal of Cardiovascular Pharmacology 44: 682–687.
18. Mitchell, M.D., R.E. Laird, R.D. Brown, and C.S. Long. 2007. IL-1beta stimulates rat cardiac fibroblast migration via MAP kinase pathways. American Journal of Physiology - Heart and Circulatory Physiology 292: H1139–1147.
19. Gong, Y.N., X.M. Wang, J.Y. Wang, Z.X. Yang, S. Li, J.L. Yang, L.P. Liu, X.G. Lei, and F. Shao. 2010. Chemical probing reveals insights into the signaling mechanism of inflammasome activation. Cell Research 20: 1289–1305.
20. Colomar, A., V. Marty, C. Médina, C. Combe, P. Parnet, and T. Amédée. 2003. Maturation and release of interleukin-1beta by lipopolysaccharide-primed mouse Schwann cells require the stimulation of P2X7 receptors. Journal of Biological Chemistry 278: 30732–30740.
21. Kumar, A., Y. Takada, A.M. Boriek, and B.B. Aggarwal. 2004. Nuclear factor-κB: its role in health and disease. Journal of Molecular Medicine (Berlin) 82: 434–448.
22. Bai, D., L. Ueno, and P.K. Vogt. 2009. Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt. International Journal of Cancer 125: 2863–2870.
23. Madrid, L.V., M.W. Mayo, J.Y. Reuther, and A.S. Baldwin Jr. 2001. Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38. Journal of Biological Chemistry 276: 18934–18940.
24. Saxena, A., W. Chen, Y. Su, V. Rai, O.U. Uche, N. Li, and N.G. Frangogiannis. 2013. IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium. Journal of Immunology 191: 4838–4848.
25. Chen, W., and N.G. Frangogiannis. 2013. Fibroblasts in post-infarction inflammation and cardiac repair. Biochimica et Biophysica Acta 1833: 945–953.
26. Vermeulen, L., G. De Wilde, P. Van Damme, W. Vanden Berghe, and G. Haegeman. 2003. Transcriptional activation of the NF-kappaB p65 subunit by mitogen-and stress-activated protein kinase-1 (MSK1). The EMBO Journal 22: 1313–1324.
27. Lee, Y.Y., J.S. Park, J.S. Jung, D.H. Kim, and H.S. Kim. 2013. Anti-inflammatory effect of Ginsenoside Rg5 in lipopolysaccharide-stimulated BV2 microglial cells. International Journal of Molecular Sciences 14: 9820–9833.
28. Zhu, J.Y., L. Jiang, Y.Q. Liu, W.Y. Qian, J.L. Liu, J. Zhou, R. Gao, H. Xiao, and J. Wang. 2014. MAPK and NF-κB pathways are involved in bisphenol A-induced TNF-α and IL-6 production in BV2 microglial cells. Inflammation. doi:10.1007/s10753-014-9971-5.
29. Li, G.F., J.H. Fu, Y. Zhao, K.Q. Ji, T. Luan, and B. Zang. 2014. Alpha-lipoic acid exerts anti-inflammatory effects on lipopolysaccharide-stimulated rat mesangial cells via inhibition of nuclear factor Kappa B (NF-κB) signaling pathway. Inflammation. doi:10.1007/s10753-014-9957-3.
30. Nagamatsu, Y., M. Nishida, N. Onohara, M. Fukutomi, Y. Maruyama, H. Kobayashi, Y. Sato, and H. Kurose. 2006. Heterotrimeric G protein G alpha13-induced induction of cytokine mRNAs through two distinct pathways in cardiac fibroblasts. Journal of Pharmacological Sciences 101: 144–150.
31. Yasuda, T. 2011. Hyaluronan inhibits Akt, leading to nuclear factor-κB down-regulation in lipopolysaccharide-stimulated U937 macrophages. Journal of Pharmacological Sciences 115: 509–515.